Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease
Science Advances · 01.05.2026 · 12 (18)
DOI: 10.1126/sciadv.aec6955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 01.05.2026. Verfasst von Di Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Brain Science and Disease, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Shandong Provincial Key …. Hauptthemen laut MEDLINE: Subthalamic Nucleus, Ultrasonic Waves, Nanoparticles, Parkinson Disease, Secondary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Traditional deep-brain stimulation via implanted electrodes can effectively treat neurological disorders, but surgical injury limits its clinical application. Here, we developed ultrasound-responsive piezoelectric nanoparticles for minimal-invasive and wireless neuromodulation. In the 6-OHDA–induced Parkinson’s disease (PD) mouse model, these nanoparticles are injected into the subthalamic nucleus (STN) of the mouse brain. After ultrasound stimulation for several days, the motor behavior, particularly gait abnormalities and nonmotor symptoms such as pain and anxiety, in PD mice is alleviated without detectable toxicity. The piezoelectric nanoparticles can activate the STN area of the mouse after ultrasound stimulation. Our results demonstrate that piezoelectric-mediated neuromodulation of the STN reverses motor deficits in PD by modulating neural signals, thereby protecting dopaminergic neurons and enhancing levels of the neurotransmitter dopamine. This process can rescue and mitigate mitochondrial dysfunction and neuroinflammation in the nigrostriatal pathway. Our approach enables STN neuronal activation with minimal invasiveness, offering a promising strategy for treating neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Brain Science and Disease, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Q…
- Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong 999077, P. R. China.
ORCID-Profile: Di Zhao, Weng Fu Io, Juntao Cui, Jianhua Hao, Limin Shi, Junxia Xie
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province
- Hong Kong Scholars Program
- Hong Kong Polytechnic University
Zitieren
APA
Zhao, D., Zhong, G., Cao, Z., Io, W. F., Guo, F., Cui, J., Qu, L., Hao, J., Shi, L., & Xie, J. (2026). Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease. Science Advances, 12(18). https://doi.org/10.1126/sciadv.aec6955
Vancouver
Zhao D, Zhong G, Cao Z, Io WF, Guo F, Cui J, et al. Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease. Science Advances. 2026;12(18). doi:10.1126/sciadv.aec6955
BibTeX
@article{Zhao2026,
author = {Zhao, Di and Zhong, Guangjun and Cao, Zhengyang and Io, Weng Fu and Guo, Feng and Cui, Juntao and Qu, Le and Hao, Jianhua and Shi, Limin and Xie, Junxia},
title = {Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {18},
doi = {10.1126/sciadv.aec6955}
}
EUVIMED